Metabolism and toxicity of the new anesthetic agents

Acta Anaesthesiologica Belgica

Volumn 47, Issue 1, 1996, Pages 7-14

  Kharasch, E D ^a,b  

^a Dept of Anesth and Med Chemistry ^*  (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

anesthetics, volatile: methoxyflurane, sevoflurane, enflurane, isoflurane, desflurane; ion: fluoride; kidney: function, toxicity, metabolism; liver: function, toxicity, metabolism, hepatitis; metabolism: cytochrome P450, hepatic, renal; toxicity: fluoride, sevoflurane, desflurane, immune

Indexed keywords

DESFLURANE; DRUG METABOLITE; FLUORIDE; HEXAFLUORO 2 PROPANOL; METHOXYFLURANE; SEVOFLURANE; TRIFLUOROACYL CHLORIDE; UNCLASSIFIED DRUG;

ANESTHESIA; BIOTRANSFORMATION; CONFERENCE PAPER; DRUG METABOLISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; NEPHROTOXICITY;

ANESTHETICS, INHALATION; BIOTRANSFORMATION; CARBON DIOXIDE; ETHERS; HUMANS; ISOFLURANE; KIDNEY; LIVER; METHYL ETHERS;

EID: 0029993714     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Ray D. C., Drummond G. B., Halothane hepatitis. BR. J. ANAESTH., 67, 84-99, 1991.
2. Cousins M. J., Plummer J. L., Hall P. M., Risk factors for halothane hepatitis, AUST. NZ J. SURG., 59, 5-14, 1989.
3. Christ D. D., Satoh H., Kenna J. G., Pohl L. R., Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane, DRUG METAB. DISP., 16, 135-140, 1988.
4. Mazze R. I., Fluorinated anaesthetic nephrotoxicity : An update, CAN. ANAESTH. Soc. J., 31, S16-S22, 1984.
5. Kharasch E. D., Hankins D. C., Thummel K. E., Human kidney methoxyflurane and sevoflurane metabolism : Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity, ANESTHESIOLOGY, 82, 689-699, 1995.
6. Kharasch E. D., Biotransformation of sevoflurane, ANESTH. ANALG., 81 : S27-S38, 1995.
7. Cousins M. J., Mazze R. I., Methoxyflurane nephrotoxicity : A study of dose response in man, JAMA, 225, 1611-1616, 1973.
8. Koblin D. D., Characteristics and implications of desflurane metabolism and toxicity, ANESTH. ANALG., 75, S10-S16, 1992.
9. Kharasch E. D., Thummel K. E., Identification of cytochrome P450 2EI as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane, ANESTHESIOLOGY, 79, 795-807. 1993.
10. Sutton T. S., Koblin D. D., Gruenke L. D., Weiskopf R. B., Rampil I. J., Waskell L., Eger E. I. II, Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. ANESTH. ANALG., 73, 180-185, 1991.
11. Davidkova T., Kikuchi H., Fujii K., Mukaida K., Sato N., Kawachi S., Mono M., Biotransformation of isoflurane : Urinary and serum fluoride ion and organic fluorine, ANESTHESIOLOGY, 69, 218-222, 1988.
12. Jones R. M., Koblin D. D., Cashman J. N., Eger E. I. II, Johnson B. H., Damask M. C., Biotransformation and hepato-renal function in volunteers after exposure to desflurane (I-653), BR. J. ANAESTH., 64, 482-487, 1990.
13. Smiley R. M., Ornstein E., Pantuck E. J., Matteo R. S., Metabolism of desflurane and isoflurane to fluoride ion in surgical patients, CAN. J. ANAESTH., 38, 965-968, 1991.
14. Frink E. J. Jr., The hepatic effects of sevoflurane, ANESTH. ANALG., 81, S46-S50, 1995.
15. Martin J. L., Plevak D. J., Flannery K. D., Charlton M., Poterucha J. J., Humphreys C. E., Derfus G., Pohl L. R., Hepatotoxicity after desflurane anesthesia, ANESTHESIOLOGY, 83, 1125-1129, 1995.
16. Holaday D. A., Smith F. R., Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers, ANESTHESIOLOGY, 54, 100-106, 1981.
17. Fujii K., Morio M., Kikuchi H., Mukaida K., Sato N., Yuge O., Kawahara M., Pharmacokinetic study on excretion of inorganic fluoride ion, a metabolite of sevoflurane, HIROSHIMA J. MED. Sci., 36, 89-92, 1987.
18. Davidkova T. I., Fujii K., Kikuchi H., Horibe M., Mukaida K, Sato N., Morio M., Urinary excretion of inorganic and organic fluoride after inhalation of sevoflurane, HIROSHIMA J. MED. SCI., 36, 99-104, 1987.
19. Kikuchi H., Morio M., Fujii K., Mukaida J., Horibe M., Davidkova T. I., Kawachi S., Sato N., Clinical evaluation and metabolism sevoflurane in patients, HIROSHIMA J. MED. SCI., 36, 93-97, 1987.
20. Kharasch E. D., Karol M. D., Lanni C., Sawchuk R., Clinical sevoflurane metabolism and disposition : I. Sevoflurane and metabolite pharmacokinetics, ANESTHESIOLOGY, 82 : 1369-1378, 1995.
21. Frink E. J. Jr., Malan T. P. Jr., Isner J., Brown E. A., Morgan S., Brown B. R. Jr., Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers, ANESTHESIOLOGY, 80, 1019-1025, 1994.
22. Frink E. J. Jr., Ghantous H., Malan T. P., Morgan S., Fernando J., Gandolfi A. J., Brown B. R. Jr., Plasma inorganic fluoride with sevoflurane anesthesia : Correlation with indices of hepatic and renal function, ANESTH. ANALG., 74, 231-235, 1992.
23. Kobayashi Y., Ochiai R., Takeda J., Sekiguchi H., Fukushima K., Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans. ANESTH. ANALG., 74, 753-757, 1992.
24. 2O anesthesia, ANESTH. ANALG., 74, 253-259. 1992.
25. Kharasch E. D., Armstrong A. S., Gunn K., Artru A., Cox K., Clinical sevoflurane metabolism and disposition : II. The role of cytochrome P450 2EI in fluoride and hexafluoroisopropanol formation. ANESTHESIOLOGY, 82, 1379-1388, 1995.
26. Lerman J., Sikich N., Kleinman S., Yentis S., The pharmacology of sevoflurane in infants and children, ANESTHESIOLOGY, 80, 814-824, 1994.
27. Shiraishi Y., Ikeda K, Uptake and biotransformation of sevoflurane in humans : A comparative study of sevoflurane with halothane, enflurane, and isoflurane, J. CLIN. ANESTH., 2 : 381-386, 1990.
28. Carpenter R. L., Eger E. I. II, Johnson B. H., Unadkat J. D., Sheiner L. B., The extent of metabolism of inhaled anesthetics in humans, ANESTHESIOLOGY, 65, 201-205, 1986.
29. Higuchi H., Satoh T., Arimura S., Kanno M., Endoh R., Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia, ANESTH. ANALG., 77, 1018-1021, 1993.
30. Apfelbaum J. L., Zacny J. P., Lichtor J. L., Thapar P., O'Connor M. F., Binstock W., Coalson D., Lane B., Phenobarbital and the defluorination of sevoflurane in healthy male volunteers, ANESTHESIOLOGY, 81, A364, 1994.
31. Matsumura C., Kemmotsu O., Kawano Y., Takita K., Sugimoto H., Mayumi T., Serum and urine inorganic fluoride levels following prolonged low-dose sevoflurane anesthesia combined with epidural block, J. CLIN. ANESTH., 6, 419-424, 1994.
32. Munday I. T., Stoddart P. A., Jones R. M., Lytle J., Cross M. R., Serum fluoride concentration and urine osmolality after enflurane and sevoflurane anesthesia in male volunteers, ANESTH. ANALG., 81, 353-359, 1995.
33. Conzen P. F., Nuscheler M., Melotte A., Verhaegen M., Leupolt T., Van Aken H., Peter K., Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane, ANESTH. ANALG., 81, 569-575, 1995.
34. Higuchi H., Sumikura H., Sumita S., Arimura S., Takamatsu F., Kanno M., Satoh T., Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia, ANESTMESIOLOGY, 83, 449-458, 1995.
35. Morio M., Fujii K, Satoh N., Imai M., Kawakami U., Mizuno T., Kawai Y., Ogasawara Y., Tamura T., Negishi A., Kumagai Y., Kawai T., Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts, ANESTHESIOLOGY. 77, 1155-1164, 1992.
36. Gonsowski C. T., Laster M. J., Eger E. I. II, Ferrell L. D., Kerschmann R. L., Toxicity of compound A in rats. Effect of increasing duration of administration, ANESTHESIOLOGY, 80, 566-573, 1994.
37. Keller K. A., Callan C., Prokocimer P., Delgado Herrera M. S., Friedman M. B., Hoffman G. M., Wooding W. L., Cusick P. K., Krasula R. W., Inhalation toxicology study of a haloalkene degradant of sevoflurane in Sprague-Dawley rats, ANESTHESIOLOGY, in press, 1995.
38. 2 absorbants during low-flow anesthesia in surgical patients, ANESTHESIOLOGY, 77, 1064-1069, 1992.
39. Frink E. J. Jr., Isner R. J., Malan T. P. Jr., Morgan S., Brown E. A., Brown B. R. Jr., Sevoflurane degradation product concentrations with soda lime during prolonged anesthesia, J. CLIN. ANESTH., 6, 239-242, 1994.
40. Bito H., Ikeda K., Closed-circuit anesthesia with sevoflurane in humans : Effects on renal and hepatic function and concentrations of breakdown products with soda lime in the circuit, ANESTHESIOLOGY, 80, 71-76, 1994.
41. Bito H., Ikeda K., Plasma inorganic fluoride and intracircuit degradation product concentrations in long-duration, low-flow sevoflurane anesthesia, ANESTH. ANALG., 79, 946-951, 1994.
42. Bito H., Ikeda K., Degradation products of sevoflurane during low-flow anaesthesia, BR. J. ANAESTH., 74, 56-59, 1995.
43. Jin L., Baillie T. A., Davis M. R., Kharasch E. D., Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether] in rats : Evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate β-lyase, BIOCHEM. BIOPHYS. RES COMMUN., 210, 498-506, 1995.
44. Fang Z., Eger E. I. II, Laster M. J., Chortkoff B. S., Kandel L., Ionescu P., Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane and sevoflurane by soda lime and Baralyme, ANESTH. ANALG., 80, 1187-1193, 1995.
45. Kharasch E. D., Inhalation anesthetic toxicity : Current controversies, ASA Refresher Course Lectures, LECTURE 264, 1995.
46. Frink E. J. Jr., Desflurane anesthesia using dry Baralyme produces high carboxyhemoglobin levels in pigs, ANESTHESIOLOGY, 83, A294, 1995.